Raffi Asadorian

2017 - AcelRx Pharmaceuticals

In 2017, Raffi Asadorian earned a total compensation of $606.3K as Chief Financial Officer at AcelRx Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$34,200
Option Awards$420,087
Salary$150,000
Other$2,000
Total$606,287

Asadorian received $420.1K in option awards, accounting for 69% of the total pay in 2017.

Asadorian also received $34.2K in non-equity incentive plan, $150K in salary and $2K in other compensation.

Rankings

In 2017, Raffi Asadorian's compensation ranked 11,151st out of 14,666 executives tracked by ExecPay. In other words, Asadorian earned more than 24.0% of executives.

ClassificationRankingPercentile
All
11,151
out of 14,666
24th
Division
Manufacturing
4,359
out of 5,768
24th
Major group
Chemicals And Allied Products
1,578
out of 2,074
24th
Industry group
Drugs
1,298
out of 1,730
25th
Industry
Pharmaceutical Preparations
1,011
out of 1,329
24th
Source: SEC filing on April 23, 2018.

Asadorian's colleagues

We found seven more compensation records of executives who worked with Raffi Asadorian at AcelRx Pharmaceuticals in 2017.

2017

Vincent Angotti

AcelRx Pharmaceuticals

Chief Executive Officer

2017

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2017

Howard Rosen

AcelRx Pharmaceuticals

Chief Executive Officer

2017

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

2017

Lawrence Hamel

AcelRx Pharmaceuticals

Chief Development Officer

2017

Timothy Morris

AcelRx Pharmaceuticals

Chief Financial Officer

2017

Jane Wright-Mitchell

AcelRx Pharmaceuticals

Chief Legal Officer

News

In-depth

You may also like